🇺🇸

US SEC Filing Intelligence

· daily

US SEC Trading Suspension Halt Orders — July 02, 2026

The digest covers 7 filings related to trading suspensions and delistings, all from Nasdaq-listed companies facing compliance issues or voluntary termination. Six companies received deficiency notices for failing to meet the $1.00 minimum bid price requirement, with compliance deadlines set for December 28, 2026. Boxlight Corp received a delisting notice for failing to meet the $2.5 million stockholders' equity requirement and plans to appeal. MV Oil Trust voluntarily delisted from the NYSE due to trust dissolution, with final distribution on July 24, 2026. The predominant theme is the risk of delisting for small-cap companies, with many considering reverse stock splits as a remedy. No insider trading activity, revenue growth trends, or capital allocation changes were reported in these filings, limiting quantitative comparisons. The most critical development is Boxlight's imminent delisting risk, given its failure to meet equity standards and reliance on uncertain financing.

7 high priority 7 total filings
· daily

US Executive Officer Management Changes SEC — July 02, 2026

The July 2, 2026, filings reveal a significant wave of executive and director changes, with the most prominent pattern being a coordinated CFO transition across 12 Grayscale crypto trusts, where Edward McGee departed after 7 years and was replaced by internal co-CFOs Kathryn Masci and Daniel Plourde. This signals a strategic consolidation of financial leadership at the sponsor level, not a trust-specific issue. Outside of Grayscale, notable appointments include a BMW executive to Solid Power's board, a Carnival Cruise president to Hilton Grand Vacations, and a new COO at Six Flags, all indicating strategic partnerships and operational focus. However, several departures raise concerns: Coty Inc. is losing three senior leaders, and Halozyme Therapeutics lost its COO without naming a successor. Compensation trends show significant increases for key executives at Bel Fuse (CEO +20.8% salary, +56.3% LTI) and Delek US (new CFO +8% salary, +20% bonus target), signaling confidence in future performance. The overall sentiment is neutral, with specific positive signals from strategic board appointments and negative signals from unexpected departures and governance changes.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 02, 2026

The 50 filings reveal a pronounced bifurcation in corporate health: while several companies are securing substantial capital (BridgeBio $1B, NextDecade $3.5B, Neurogene $134.8M) and extending credit lines (Haverty +$20M, Cheniere +$500M), a cluster of distressed firms are fighting for survival through high-cost debt (American Rebel 36.6% effective rate), repeated maturity extensions (CareView 15th amendment), and reverse stock splits (Snail 1-for-5). Distress signals dominate: 5 companies received Nasdaq deficiency notices (RenovoRx, HeartBeam, ALT5 Sigma, Boxlight, Snail), 1 approved liquidation (Origin Materials), and 1 faces delisting (Boxlight). Period-over-period data is sparse but shows HUMBL's revenue growing 20% YoY while losses widen, and Centrus Energy securing a $900M DOE contract but with first capacity not until 2029. Insider activity is limited but includes CEO Nicholas Liuzza receiving shares at a premium in Beeline Holdings. The overarching theme is capital access as a differentiator—well-capitalized firms are investing for growth, while cash-strapped firms resort to dilutive or expensive financing.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 02, 2026

This digest of 50 SEC filings reveals a significant leadership restructuring event at Grayscale Investments, with the departure of CFO Edward McGee after 7 years and the appointment of interim Co-CFOs across 19 crypto trust ETFs, representing a coordinated internal succession. Beyond this, the period shows a notable trend of strategic board appointments from key partners (BMW's Uwe Breitweg to Solid Power, Carnival's Christine Duffy to Hilton Grand Vacations) and several senior executive departures at Coty, Halozyme, and Conduent, signaling potential strategic pivots. Compensation actions are mixed: Bel Fuse significantly increased CEO/CFO pay (20-56% raises), while Arcadia Biosciences cut total CEO compensation by 5.3% YoY. A key forward-looking event is the upcoming commercial launch of CapsoVision's AI-assisted reading feature. Overall, the digest highlights a period of active board and management refreshment, with a focus on retaining talent through retention plans (Xerox) and retention awards (ADC Therapeutics), while several companies are streamlining their executive structures (Trulieve eliminating CAO role, Delek US Holdings reshuffling C-suite).

50 high priority 50 total filings
· daily

USA Insider Trading Pulse — July 02, 2026

The July 2, 2026, insider trading pulse reveals a market dominated by routine, non-discretionary transactions (awards, tax withholdings, deferred units) with limited high-conviction signals. The most significant outlier is a substantial open-market purchase by the CEO of Wallbox N.V., signaling strong insider confidence in the EV charging company's turnaround at a depressed valuation. Outside of this, the data is largely neutral, with a notable concentration of director stock awards at ICF International and Dare Bioscience, suggesting routine compensation cycles rather than strategic positioning. A single pre-planned sale by a director at 908 Devices and a large tax-withholding by the President of TPG RE Finance Trust are the primary risk flags, indicating potential liquidity pressure or personal portfolio management. The overall theme is one of low conviction, with the Wallbox purchase being the only actionable, high-signal event for investors seeking to follow insider sentiment.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 02, 2026

Overnight filings reveal a market bifurcated between aggressive insider selling by major stakeholders and significant corporate actions like spin-offs and capital raises. The most prominent theme is large-scale insider profit-taking, with Fairmount Funds selling $300M of Oruka Therapeutics and a key Intuitive Machines insider selling at sharply declining prices, signaling potential tops in high-growth names. Conversely, the successful spin-off of Mobility Global from S&P Global and a new $18M copper project financing highlight value-creation events. Capital allocation is mixed, with Coca-Cola Europacific Partners announcing a €500M buyback tranche, while cash-strapped micro-caps like Nitches Inc. face existential liquidity crises. The data suggests investors should favor event-driven opportunities (spin-offs, IPOs) over momentum names showing insider distribution, and remain vigilant on balance sheet risks in the small-cap space.

36 high priority 14 medium 50 total filings
· daily

New Federal Contractors — July 01, 2026

This digest covers four federal contracts totaling $1.66 billion, all civilian (0/4 defense-related), with an average signal strength of 6.0/10. The dominant award is a $1.24 billion contract to Harris Corporation from the Department of Transportation, representing 75% of total obligation and the highest-conviction bullish signal (materiality 8/10), though contract details are sparse, creating uncertainty. Leidos, Inc. secured a $113.5 million NIH contract for agile software development, reinforcing civilian IT modernization trends, while Amentum Services (Jacobs Engineering) and Management & Training Corporation face near-term revenue cliffs due to contract expirations in 2023 and 2024, respectively. Key risks include concentration in a single opaque award and re-compete exposure for Amentum and MTC.

4 total filings
· daily

Contract Deobligations Alert — July 01, 2026

This digest covers $1.66 billion in total obligations across four contracts, all civilian (0/4 defense-related), signaling a concentrated shift toward non-DOD federal spending. The dominant theme is large, sole-source or long-duration civilian IT and services awards, with Harris Corporation's $1.24B Department of Transportation contract accounting for 75% of aggregate value and representing the highest-conviction bullish signal. Amentum Services ($204M NASA) and Leidos ($113.5M NIH) add to the civilian IT/services narrative, while Management & Training Corporation's $103.8M DOL Job Corps contract introduces near-term recompete risk. Key risk: the Harris contract's age (2011) and lack of pricing/competition data create uncertainty around current performance and margin trajectory.

4 total filings
· daily

Contract Option Exercises — July 01, 2026

This digest covers $1.66 billion in contract option exercises during a single day, entirely from civilian agencies with zero defense exposure—a stark divergence from the typical DOD-heavy procurement mix. The dominant theme is infrastructure and IT modernization across civilian agencies, led by a massive $1.24 billion Harris Corporation award from the Department of Transportation that singularly accounts for 75% of total value. Amentum Services (Jacobs Engineering) and Leidos secured low-risk cost-plus contracts totaling $317.6 million from NASA and NIH, reinforcing stable civilian technology services revenue, while Management & Training Corporation faces near-term execution risk as its $103.8 million DOL Job Corps contract approaches expiry. Key risk: the concentration of 75% of value in one contract to Harris Corporation creates an outsized dependency on DOT budget execution and potential continuing resolution disruptions.

4 total filings
· daily

Federal IT & Cybersecurity Contracts — July 01, 2026

This digest covers a single, high-value civilian contract totaling $113.5 million awarded to Leidos, Inc. by the National Institutes of Health (NIH) for agile software development supporting the eRA grants management system. The contract is entirely civilian (0% defense-related) and carries a bullish signal with a 7/10 strength, driven by a cost-plus-fixed-fee pricing structure that reduces execution risk for Leidos. The award underscores sustained federal investment in health IT modernization, though the key risk is whether the $247.1 million in options are exercised, which would double the contract's value and confirm long-term NIH commitment. The aggregate obligation is material for Leidos's federal IT services segment, but the lack of defense exposure limits broader sector implications.

1 total filings
· daily

All HHS Contracts — July 01, 2026

This digest covers a single, large civilian contract from the Department of Health and Human Services (HHS) during the period, totaling $113.5 million in obligations. The award, a cost-plus-fixed-fee delivery order to Leidos, Inc. from the National Institutes of Health (NIH), is a bullish signal for the company's federal IT services franchise, particularly in health research IT. The contract supports the NIH's eRA grants management system, aligning with federal digital modernization priorities. The key risk is whether the contract's options (up to $247.1 million total) are exercised, which would confirm sustained NIH investment. There are no defense-related contracts in this period.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — July 01, 2026

This digest covers four mega contracts totaling $1.66 billion, all from civilian agencies with zero defense exposure, signaling a pronounced shift in federal procurement focus toward non-DOD spending. The dominant theme is a massive $1.24 billion sole-source award to Harris Corporation from the Department of Transportation, representing 75% of aggregate value and carrying the highest-conviction bullish signal. Amentum Services (Jacobs Engineering) and Leidos secured cost-plus contracts with stable margins, while Management & Training Corporation faces near-term revenue uncertainty as its DOL Job Corps contract nears expiration. Key risk: the Harris award’s age (2011) and opaque pricing/competition details limit confidence, and the Amentum contract ends in August 2023, creating a recompete catalyst.

4 total filings
· daily

High-Value Federal Grants ($5M+) — July 01, 2026

This digest covers four high-value federal grants totaling $1.66 billion, with zero defense-related awards, signaling a pure civilian-sector spending story. The overwhelming bulk of value comes from a single $1.24 billion Department of Transportation award to HARRIS CORPORATION, which dominates the aggregate and drives a bullish signal, though details on pricing, revenue materiality, and competitive dynamics are conspicuously absent. Amentum Services (Jacobs Engineering) and Leidos secured notable cost-plus-fixed-fee contracts from NASA and NIH respectively, offering stable, lower-risk revenue streams. The highest-conviction signal is Leidos' $113.5M NIH award for agile software development, which aligns with federal IT modernization trends and has significant option upside. Key risks include the impending expiration of Amentum's NASA contract (August 2023) and the Management & Training Corporation's DOL Job Corps contract (November 2024), both creating near-term revenue uncertainty without clear recompete visibility.

4 total filings
· daily

General Federal Contracts — July 01, 2026

This digest covers four civilian agency contracts totaling $1.66 billion, with zero defense-related awards, underscoring a pure civilian-sector procurement theme. The dominant signal is a massive $1.24 billion award to Harris Corporation from the Department of Transportation, which accounts for 74% of total obligation and carries the highest materiality score (8/10). However, the contract's age (2011) and lack of pricing or competition details raise execution and transparency risks. The other three awards—to Amentum Services (Jacobs), Leidos, and Management & Training Corporation—are smaller, lower-conviction signals (neutral to bullish) tied to NASA, NIH, and DOL, respectively. Key watch items include the impending end of Amentum's NASA contract (August 2023) and the Atterbury Job Corps recompete (November 2024). The highest-conviction bullish signal is Leidos' $113.5 million NIH delivery order, which benefits from cost-plus pricing and federal IT modernization tailwinds.

4 total filings
· daily

All NASA Contracts — July 01, 2026

This digest covers a single NASA contract worth $204 million awarded to Amentum Services, Inc., a subsidiary of Jacobs Engineering Group, for laboratory support services at Kennedy Space Center. The contract is entirely civilian (0% defense-related) and carries a neutral signal with moderate materiality. The cost-plus-fixed-fee structure reduces profit risk for Jacobs, but the contract is nearing its end (August 2023), limiting future upside. The key risk is the lack of a renewal or recompete trigger, which could create a revenue gap for Jacobs. The highest-conviction signal is the stable, low-risk revenue stream from the $154 million already outlayed, but the near-term expiration warrants close monitoring.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 01, 2026

The 19 filings for the S&P 500 Technology sector reveal a pronounced insider selling pattern, with 6 out of 9 unique companies showing significant dispositions, including a massive $35.2M sale by Applied Materials' CEO and a $9.98M sale by Snowflake's director. This broad-based selling, largely executed under 10b5-1 plans, suggests a pre-planned but nonetheless notable cash-out event across the sector. Concurrently, AMD's 8-K filing highlights a forward-looking compensation structure heavily tied to performance-based equity, with a unique downside cap if TSR is negative, signaling a focus on sustainable growth. The data lacks period-over-period comparisons or financial metrics, preventing trend analysis, but the insider activity alone points to a potential peak in management conviction at current elevated valuations. The stream's focus on technology is maintained, with all filings relevant to the S&P 500 Technology sector.

18 high priority 1 medium 19 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 01, 2026

The seven filings from NASDAQ-100 constituents reveal a mixed picture of insider sentiment, with notable divergence between executive selling at Applied Materials and Alphabet versus routine director awards at Qualcomm and Microsoft. The most material signal is the CEO of Applied Materials selling $35.2M in stock, representing a significant reduction in his holdings, while Alphabet's President/CLO executed a pre-planned sale of $841K. On the compensation front, AMD's board approved CEO Lisa Su's base salary increase to $1.375M and a $36M target equity award, with performance metrics tied to TSR and EPS growth through 2029, signaling confidence in long-term execution. No period-over-period financial comparisons or guidance changes were present in these filings, as they are primarily insider transaction and compensation disclosures. The overall theme is one of insider profit-taking at elevated valuations in the semiconductor and tech space, contrasted with routine director compensation that carries no negative signal. Investors should monitor whether the selling at Applied Materials and Alphabet precedes broader sector weakness or is simply personal portfolio diversification.

5 high priority 2 medium 7 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 01, 2026

This intelligence stream covering 30 filings from July 1, 2026, reveals a period of significant portfolio repositioning and corporate control changes. The most critical development is the completion of the **Select Medical Holdings Corp.** take-private merger at $16.50/share, a high-materiality event that removes a major healthcare player from public markets. Concurrently, we see notable activist and institutional exits: **Glazer Capital** fully exited **Clearwater Analytics** (8/10 materiality), **PW Partners** reduced its **BJ's Restaurants** stake to below 5% (8/10 materiality), and **Bard Associates** completely liquidated its **Perfect Moment Ltd.** position. On the active ownership front, **CIM Group** filed a new Schedule 13D disclosing a 67.5% economic and voting stake in **CIM Real Estate Finance Trust** following a major asset acquisition, signaling a strong insider control structure. Insider activity is mixed; while **Ronald Boreta** of **Agassi Sports Entertainment** increased his stake through private purchases, **Patrick Walsh** of **BJ's Restaurants** sold over $2M in shares. The data shows a clear trend of large, passive institutional investors reducing or exiting positions, while insiders and strategic investors are consolidating control in specific entities. Period-over-period comparisons were limited in these filings, but the aggregate activity points to a market where conviction is concentrated in a few hands, and liquidity is being provided by sellers.

10 high priority 20 medium 30 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 01, 2026

This batch of 17 filings from the S&P 500 Financials sector is dominated by routine director equity awards and a single capital markets transaction, resulting in a low overall signal-to-noise ratio. The most material development is Morgan Stanley Direct Lending Fund's (MSDL) $350 million debt issuance at a 6.100% coupon, signaling a strategic move to lock in long-term financing in a potentially peaking rate environment. The remaining filings are uniformly neutral, consisting of standard director stock grants at Travelers, JPMorgan Chase, and T. Rowe Price, and a director option exercise at Allstate. These awards provide no actionable trading signals regarding management conviction or company outlook. The key takeaway is the absence of any negative insider selling, guidance changes, or deteriorating financial trends, but also a lack of bullish catalysts. The sector appears to be in a quiet period, with the MSDL debt offering being the only event warranting deeper analysis for fixed-income investors.

17 high priority 17 total filings